---
title: "000650.SZ (000650.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000650.SZ/news.md"
symbol: "000650.SZ"
name: "000650.SZ"
parent: "https://longbridge.com/en/quote/000650.SZ.md"
datetime: "2026-03-13T23:51:24.433Z"
locales:
  - [en](https://longbridge.com/en/quote/000650.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000650.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000650.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/000650.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/000650.SZ/news.md)


# 000650.SZ (000650.SZ) — Related News

### [RPC: The company produces and sells Oseltamivir Phosphate Capsules](https://longbridge.com/en/news/276978422.md)
*2026-02-26T03:46:43.000Z*
> On February 26th, RPC stated on the interactive platform that the company produces and sells Oseltamivir Phosphate Capsu

### [RPC: Participated in the Poman (Zhuhai) Venture Capital Fund, with an investment share of 30%](https://longbridge.com/en/news/274735626.md)
*2026-02-04T01:07:20.000Z*
> RPC announced its participation in the Poman (Zhuhai) Venture Capital Fund, with an investment share of 30%. The registe

### [RPC: The company currently has products available for consumers to use for symptoms related to rhinovirus infections](https://longbridge.com/en/news/272233899.md)
*2026-01-12T07:52:24.000Z*
> RPC stated on the interactive platform on January 12 that there are currently no specific drugs or vaccines for the prev

### [Pharmaceutical companies' "private label" business: RPC once earned over 2 billion annually](https://longbridge.com/en/news/272033294.md)
*2026-01-09T06:46:14.000Z*
> The "private label" model of pharmaceutical companies has sparked heated discussions, referring to the practice where br

### [Announcement from the listed company on December 29, 2025](https://longbridge.com/en/news/270981311.md)
*2025-12-29T09:46:30.000Z*
> On December 29, 2025, RPC announced that its controlling shareholder did not reduce its shareholding and prematurely ter

### [RPC: The controlling shareholder, Renhe Group, has not reduced its holdings and has prematurely terminated its share reduction plan](https://longbridge.com/en/news/270971744.md)
*2025-12-29T09:01:48.000Z*
> RPC announced that as of the date of this announcement, its controlling shareholder, Renhe Group, has not actually reduc

### [RPC: Termination of fundraising projects and permanent replenishment of working capital](https://longbridge.com/en/news/269051291.md)
*2025-12-09T07:57:02.000Z*
> RPC announced plans to adjust the investment scale of the "Digital Intelligent Transformation and Relocation of Women's 

### [RPC: Is working hard to promote the official launch and sale of ULOOK glasses as soon as possible](https://longbridge.com/en/news/268371706.md)
*2025-12-03T07:31:10.000Z*
> On December 3rd, RPC stated on the interactive platform that the company is currently working hard to promote the offici

### [RPC's controlling shareholder plans to reduce holdings by no more than 3 million shares](https://longbridge.com/en/news/265724124.md)
*2025-11-13T12:25:02.000Z*
> According to the announcement from Dolphin Research, RPC announced that its controlling shareholder, Renhe (Group) Devel